PROFUND ADVISORS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,456,817
-0.0%
151,279
+10.4%
0.08%
+3.8%
Q2 2023$1,457,467
+14.0%
136,980
+12.7%
0.08%
-1.3%
Q1 2023$1,278,127
+461.1%
121,495
+560.8%
0.08%
+426.7%
Q4 2022$227,803
+20.5%
18,386
+1.0%
0.02%
+7.1%
Q3 2022$189,000
-23.8%
18,205
-15.4%
0.01%
-12.5%
Q2 2022$248,000
+38.5%
21,527
+50.9%
0.02%
+100.0%
Q1 2022$179,000
+0.6%
14,266
-6.3%
0.01%
+33.3%
Q4 2021$178,000
-6.3%
15,232
+4.6%
0.01%0.0%
Q3 2021$190,000
-8.7%
14,569
-9.8%
0.01%
-14.3%
Q2 2021$208,000
+20.9%
16,154
+5.0%
0.01%0.0%
Q1 2021$172,000
+4.2%
15,392
+6.4%
0.01%0.0%
Q4 2020$165,000
+34.1%
14,464
+5.4%
0.01%
+16.7%
Q3 2020$123,000
-17.4%
13,729
-5.0%
0.01%
-25.0%
Q2 2020$149,000
+9.6%
14,452
+6.9%
0.01%
-20.0%
Q1 2020$136,000
-34.3%
13,519
-13.1%
0.01%
+11.1%
Q4 2019$207,000
+88.2%
15,558
+21.7%
0.01%
+50.0%
Q3 2019$110,000
-30.8%
12,781
-12.1%
0.01%
-25.0%
Q2 2019$159,000
-16.3%
14,537
+3.8%
0.01%
-11.1%
Q1 2019$190,000
-20.2%
14,006
-39.0%
0.01%
-40.0%
Q4 2018$238,000
-51.6%
22,960
-13.9%
0.02%
-21.1%
Q3 2018$492,00026,6660.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders